+91-98 455 710 46 | info@nckpharma.com

Pharma News

Keep updating your pharma knowledge
28 Nov 2020

Covid 19 Vaccine development and commercialization status | More than 50 vaccine candidate under development

Posted By

More than 50 covid-19 vaccine candidate is currently under development. Here you can have the close look into the development status of the vaccine candidate.

Click here to view

wpDataTable with provided ID not found!

Till date following 2 vaccine candidate is approved.

1. Sputnik V – formerly known as Gam-COVID-Vac and developed by the Gamaleya Research Institute in Moscow – was approved by the Ministry of Health of the Russian Federation on 11 August.

2. EpiVacCorona

Leave a Reply

The reCAPTCHA verification period has expired. Please reload the page.

Upskill Your Pharma Knowledge

Explore Next Gen Learning

Case Studies & Caselets | Simulation Based Learning | E-Lectures | Online Self Competency Assessments

Thank You for Subscription!